In addition, upregulation of MEG3 could suppress tumour growth and cell proliferation in gemcitabine-resistant NSCLC by modulating PTEN signalling-mediated cell apoptosis [45]. This evidence concerns the gene PTEN and non-small cell lung carcinoma.